Cargando…
Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial
OBJECTIVES: Levetiracetam (LEV) is a well-established broad spectrum antiseizure medication (ASM) effective in focal, generalized, and myoclonic seizures whereas lacosamide (LCM) is a comparatively newer ASM currently approved only as an add-on agent in focal seizures. The aim of the study was to as...
Autores principales: | Jaiswal, Binaya Kumar, Bhoi, Sanjeev Kumar, Jha, Menka, Samal, Priyanka, Porey, Camelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696354/ http://dx.doi.org/10.25259/JNRP_182_2023 |
Ejemplares similares
-
A Study of Organophosphorus Induced Delayed Myelopathy: Uncommon Sequelae of a Common Poisoning
por: Porey, Camelia, et al.
Publicado: (2023) -
MOG Antibody Disease with Non-Neurological Involvement: A Chance Coincidence or a Relevant Association
por: Porey, Camelia, et al.
Publicado: (2022) -
Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy
por: Liu, Airong, et al.
Publicado: (2020) -
Atypical Presentation of Anti-MOG Ab Disease
por: Bhoi, Sanjeev K., et al.
Publicado: (2021) -
Lacosamide/levetiracetam/valproate: Lack of efficacy: case report
Publicado: (2022)